Gilgamesh Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Gilgamesh Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD (NCT06309277) | Gilgamesh Pharmaceuticals | 2024-02-01 |
| A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD (NCT06236880) | Gilgamesh Pharmaceuticals | 2024-01-31 |
Track Gilgamesh Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.